Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.59 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.59 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 5/20 | 0.49 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931960 | 1.00 | PTGER4 (0.59) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL2250015 | 0.83 | TRPA1 (0.47) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL1932534 | 0.83 | ALDH1A1 (0.55) | PTGER4PTGER3PTGER2KDM4EALDH1A1 | |
| SCHEMBL1932532 | 0.83 | ALDH1A1 (0.55) | PTGER4PTGER3PTGER2KDM4EALDH1A1 | |
| SCHEMBL24074903 | 0.83 | PTGER4 (0.61) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL3848013 | 0.78 | TRPA1 (0.63) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL9954124 | 0.78 | TRPA1 (0.63) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL8964772 | 0.76 | IDO1 (0.44) | PTGER4PTGER3PTGER2ALDH1A1TP53 | |
| SCHEMBL11429370 | 0.75 | CYP3A4 (0.57) | PTGER4PTGER3PTGER2TRPA1RELA | |
| SCHEMBL25154071 | 0.75 | GSK3B (0.63) | PTGER4PTGER3PTGER2RELAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656985-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-9656986-B2 | Compositions comprising TPGS-750-M | MYCELL TECHNOLOGIES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MYCELL TECH LLC (US) | 2016-12-01 | — | — | US | disclosed |
| US-20160340332-A1 | Compositions Comprising TPGS-750-M | MYCELL TECH LLC (US) | 2016-11-24 | — | — | US | disclosed |
| US-8785665-B2 | Surfactant-enabled transition metal-catalyzed chemistry | MYCELL TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | MyCell Holdings Limited | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340332-A1 | Compositions Comprising TPGS-750-M | S100A10, S100A6, TPR | PTGER4 1831/4885PTGER3 2116/4885PTGER2 2494/4885 |
| US-20170073322-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | PTGER4 4683/4885PTGER3 4533/4885PTGER2 4726/4885 |
| US-20110130562-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | PTGER4 4683/4885PTGER3 4533/4885PTGER2 4726/4885 |
| US-20160347677-A1 | Surfactant-Enabled Transition Metal-Catalyzed Chemistry | SOD1, SMURF1, MUC1 | PTGER4 4683/4885PTGER3 4533/4885PTGER2 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.